sTREM-1联合CC16对老年AECOPD患者预后不良的预测效能

doi:10.3969/j.issn.1671-7171.2021.10.018

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1217 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the predictive effect of soluble myeloid cell trigger receptor-1 (sTREM-1) combined with Clara cell secretory protein (CC16) on poor prognosis in elderly patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). 【Methods】A total of 206 patients with COPD treated in our hospital from February 2019 to March 2020 was selected, including 108 patients with acute exacerbation of COPD (AECOPD) (group A) and 98 patients with stable COPD (group B). In addition, 95 healthy volunteers (Group C) who underwent physical examination in our hospital at the same time were selected. The levels of serum sTREM-1 and CC16 in the three groups were compared; The incidence of poor prognosis in AECOPD patients was counted and divided into poor prognosis group and good prognosis group according to the prognosis; The clinical data of poor prognosis group and good prognosis group were compared; Logistic regression analysis was used to analyze the prognostic factors of AECOPD patients; The receiver operating characteristic curve (ROC) was made to analyze the predictive efficacy of sTREM-1 combined with CC16 in the poor prognosis of elderly AECOPD patients. 【Results】 The level of sTREM-1 in the group A and the group B was significantly higher than that in then group C (P<0.05), and the level of CC16 was significantly lower than that in the group C (P<0.05); The level of sTREM-1 in the group A was significantly higher than that in the group B (P<0.05), and the level of CC16 was significantly lower than that in the group B (P<0.05); The incidence of poor prognosis in AECOPD patients was 25.93% (28/108); The mechanical ventilation time, procalcitonin (PCT), C-reactive protein (CRP) and sTREM-1 levels in the poor prognosis group were significantly higher than those in the good prognosis group (P<0.05), while the vital capacity (FVC), forced expiratory volume in the first second (FEV1) and CC16 levels in the poor prognosis group were significantly lower than those in the good prognosis group (P<0.05); Logistic regression showed that CRP, sTREM-1 and CC16 were the influencing factors of poor prognosis in patients with AECOPD (P<0.05); ROC analysis showed that the best cutoff points for predicting the poor prognosis of elderly AECOPD patients by the levels of sTREM-1 and CC16 were 161.25 ng/L and 65.83μg/L , respectively; The specificity of the combination of sTREM-1 and CC16 was 96.25%, which was significantly higher than that of serum sTREM-1 and CC16 alone. The area under the curve (AUC) of the combination of sTREM-1 and CC16 in predicting the poor prognosis of elderly AECOPD patients was 0.923, which was higher than that of serum sTREM-1 and CC16 alone (P<0.05). 【Conclusion】sTREM-1 combined with CC16 is effective in predicting the poor prognosis of elderly AECOPD patients, and can be used to predict the poor prognosis of elderly AECOPD patients.

Key words： Pulmonary Disease, Chronic Obstructive Acute Disease Membrane Glycoproteins/BL Uteroglobin/BL Prognosis Aged

Received: 01 September 2021

PACS:

R563

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEI Dan
	CHEN Juan

Cite this article:

WEI Dan,CHEN Juan. Prognostic Value of sTREM-1 Combined with CC16 in Elderly Patients with Chronic Obstructive Pulmonary Disease[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(10): 1504-1507.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.10.018 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I10/1504

[1] AGUSTÍ A, HOGG J C. Update on the pathogenesis of chronic obstructive pulmonary disease[J].N Engl J Med,2019, 381(13):1248-1256.
[2] 王静, 刘晓鹏, 金权, 等. N-乙酰半胱氨酸对老年慢性阻塞性肺疾病患者肺功能和生活质量的影响[J].老年医学与保健, 2018, 24(3):237-239.
[3] VEGA-SÁNCHEZ Â E. Chronic obstructive pulmonary disease: perspectives for primary health care [J].Rev Invest Clin,2019, 71(1):55-63.
[4] 高春.AECOPD患者血清sTREM-1水平与炎症反应的关系及对细菌感染的诊断价值[J].国际呼吸杂志, 2020, 40(19):1503-1509.
[5] 周海, 郏琴. 重度COPD稳定期患者血清CC16, SP-D, MSP与患者肺功能,病情严重程度的关系[J].临床肺科杂志, 2019, 24(7):11-14.
[6] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)[J].国际呼吸杂志, 2012, 32(22):1681-1691.
[7] 王雯, 杨媛华. 2011版稳定期慢性阻塞性肺疾病诊治指南更新解读[J].中国医刊, 2012, 47(10):92-93.
[8] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J].国际呼吸杂志 2014, 34(1):1-11.
[9] SEGAL L N, MARTINEZ F J. Chronic obstructive pulmonary disease subpopulations and phenotyping [J].J Allergy Clin Immunol,2018, 141(6):1961-1971.
[10] GARUDADRI S, WOODRUFF P G. Targeting chronic obstructive pulmonary disease phenotypes, endotypes, and biomarkers [J].Ann Am Thorac Soc,2018, 15(4):234-238.
[11] PELLICORI P, CLELAND J G F, CLARK A L. Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy [J].Heart Fail Clin,2020, 16(1):33-44.
[12] MIRAVITLLES M, ROCHE N, CARDOSO J, et al. Chronic obstructive pulmonary disease guidelines in Europe: a look into the future [J].Respir Res,2018, 19(1):11-15.
[13] 李春华, 刘微丽. 血清HbA1c、sTREM-1与CC16联合检测对COPD患者病情程度变化的判定价值研究[J].河北医药, 2019, 41(10):56-59.
[14] 王彦宏, 郝东侠. 老年慢性阻塞性肺疾病合并呼吸衰竭病人预后影响因素分析[J].实用老年医学, 2018,32(10):970-972.
[15] ROHDE G, RADSAK M P, BORG I, et al. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease [J].Respiration,2012, 83(2):133-139.
[16] 吉训恋, 倪琼玮. 慢性阻塞性肺疾病急性加重期患者呼气冷凝液中肺部活化调节趋化因子、Clara细胞蛋白16、细胞间黏附分子1水平变化及其与患者短期预后的关系研究[J].实用心脑肺血管病杂志, 2020, 28(5):40-45.